Search results
'I quit teaching after 35 years to become a magician - I've never been happier'
Manchester Evening News via Yahoo News UK· 5 days agoHe regularly performs at weddings, stag dos, birthdays and corporate Christmas parties – some of his...
London pre-open: Stocks to edge up after mixed US session
ShareCast· 22 hours agoLondon stocks were set to nudge up at the open on Tuesday following a mixed close on Wall Street.
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance UK· 5 days agoJ&J faces the upcoming patent expiration of Stelara in 2025 and talc litigations. AbbVie, Merck,...
G1 Therapeutics' breast cancer drug fails in late-stage trial
Reuters· 2 days agoG1 Therapeutics said on Monday its drug for a rare, aggressive form of breast cancer did not meet the main goal of overall survival in a late-stage trial.
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks via Yahoo Finance UK· 6 days agoJ&J faces the upcoming patent expiration of Stelara in 2025 and talc litigations. AbbVie, Merck,...
The UK stock market is brimming with hidden value. Here are some top picks to consider in July
Motley Fool UK· 4 days agoThe UK stock market is doing well this year but things have slowed down as the summer holidays...
The UK stock market is brimming with hidden value. Here are some top picks to consider in July
Fool.co.uk via Yahoo Finance UK· 4 days agoI'm looking for the most promising shares on the UK stock market this month. Here are three that I...
London midday: Stocks pop higher as investors digest inflation reading
ShareCast· 7 days agoLondon stocks had popped into the black by midday on Wednesday as data showed that annual consumer...
London open: Stocks edge down as investors mull inflation data
ShareCast· 7 days agoLondon stocks edged lower in early trade on Wednesday as data showed that annual consumer price...
Weekly review
ShareCast· 4 days agoThe FTSE 100 ended the week up 90.86 points, or 1.12%, closing at 8,237.72 on Friday. Sales hit £1.4bn in the period, with a further £1bn of subscriptions/exhibitor revenue committed and visible ...
